Affiliation:
1. Federal state budgetary establishment «Federal center cardiovascular surgery» ; Astrakhan State Medical University
2. Federal state budgetary establishment «Federal center cardiovascular surgery»
3. Astrakhan State Medical University
Abstract
To study the diagnostic characteristics of test systems for detecting antibodies to SARS-Cov-2. We studied the diagnostic characteristics of two test systems for detecting antibodies to SARS-Cov-2, registered in the Russian Federation. The first test system is a kit for detecting total antibodies to SARS-Cov-2 using immunochemiluminescence analysis on the «Cobas e 411» analyzer («Roche Diagnostics», Germany). The second test system is a kit for detecting IgM and IgG to SARS-Cov-2 («Core Technology Co., Ltd», China) by immunochromatographic analysis. The biological material for the study was blood serum. We assessed: diagnostic sensitivity, diagnostic specificity, and predictive value of positive and negative results. In the test system for detecting total antibodies to SARS-CoV-2, using an IHLA, the diagnostic sensitivity and specificity were 100%; the predictive value of positive and negative results was 100%. In the test system for the detection of IgM and IgG to Sars-CoV-2, using IHA, diagnostic sensitivity for IgM and IgG were 100%; diagnostic specificity for IgM - 60%, for IgG - 72%; predictive value of a positive result for IgM - 60%, IgG - 68,18%; predictive value of negative results for IgM and IgG - 100%. The best diagnostic characteristics were found in the test system for the detection of total antibodies to SARS-Cov-2, which must be taken into account when deciding whether to purchase test systems for the detection of antibodies to SARS-Cov-2.
Subject
Biochemistry, medical,Medical Laboratory Technology,General Medicine
Reference11 articles.
1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J. et al. Novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020; 382(8):727–33. https://doi.org/10.1056/NEJMoa2001017
2. Cheng V.C., Lau S.K., Woo P.C., Yuen K.Y. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin. Microbiol. Rev. 2007; 20(4):660–94. https://doi.org/10.1128/CMR.00023-07
3. Huang Y., Lau S.K., Woo P.C., Yuen K.Y. CoVDB: a comprehensive database for comparative analysis of coronavirus genes and genomes. Nucleic Acids Res . 2008; 36: D504–D511. https://doi.org/10.1093/nar/gkm754
4. Guo L., Ren L., Yang S., Xiao M., Chang D., Yang F. et al Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am 2020. https://doi.org/10.1093/cid/ciaa310j
5. Haveri A., Smura T., Kuivanen S., Osterlund P., Hepojoki J., Ikonen N. et al. Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020. Euro Surveill. Bull. Eur. Sur Mal. Transm. Eur. Commun. Dis. Bull. 2020; 25. https://doi.org/10.2807/1560-7917.ES.2020.25.11.200.0266
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献